If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Toni Ibrahim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 26 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor

Lamberti, G., Faggiano, A., Brighi, N., Tafuto, S., Ibrahim, T., Brizzi, M. P., Pusceddu, S., Albertelli, M., Massironi, S., Panzuto, F., Badalamenti, G., Riccardi, F., Butturini, G., Gelsomino, F., De Divitiis, C., Modica, R., Bongiovanni, A., La Salvia, A., Torchio, M., Colao, A. & 2 others, Ferone, D. & Campana, D., 2020, In : The Journal of clinical endocrinology and metabolism. 105, 1

Research output: Contribution to journalArticle

Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor

Lamberti, G., Faggiano, A., Brighi, N., Tafuto, S., Ibrahim, T., Brizzi, M. P., Pusceddu, S., Albertelli, M., Massironi, S., Panzuto, F., Badalamenti, G., Riccardi, F., Butturini, G., Gelsomino, F., De Divitiis, C., Modica, R., Bongiovanni, A., La Salvia, A., Torchio, M., Colao, A. & 2 others, Ferone, D. & Campana, D., Jan 1 2020, In : The Journal of clinical endocrinology and metabolism. 105, 1

Research output: Contribution to journalArticle

Open Access
  • A biomimetic 3D model of hypoxia-driven cancer progression

    Liverani, C., De Vita, A., Minardi, S., Kang, Y., Mercatali, L., Amadori, D., Bongiovanni, A., La Manna, F., Ibrahim, T. & Tasciotti, E., Dec 1 2019, In : Scientific Reports. 9, 1, 12263.

    Research output: Contribution to journalArticle

    Open Access
  • Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

    Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., Sep 1 2019, In : European Journal of Cancer. 118, p. 178-186 9 p.

    Research output: Contribution to journalArticle

  • Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

    Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., 2019, In : European Journal of Cancer. 118, p. 178-186 9 p.

    Research output: Contribution to journalArticle